Buy DSUVIA Online
Buy DSUVIA Online is used for the management of acute pain, severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults. It is for a certify medically supervise healthcare setting, such as hospitals, surgical centers, and emergency departments.
Dosage of it is one 30-mcg tablet administer sublingually as need be, with a minimum of 1 hour between doses.
It allows for a flexible re-dosing interval that can meet the needs of patients across a range of demographics. Including weight and age. SHOP NOW!
CHEAP DSUVIA FOR SALE
The maximum cumulative daily dose of it is 360 mcg or 12 tablets (12 tablets x 30 mcg/dose).
We showed the safety of DSUVIA across a range of patients in multiple clinical studies
We followed 646 patients in controlled and uncontrolled studies of DSUVIA or equivalent doses of sublingual sufentanil. The largest controlled study of DSUVIA was the abdominal surgery pivotal trial (N=161).
DSUVIA contains sufentanil, a Schedule II control substance. As an opioid, DSUVIA exposes users to the risks of addiction, abuse, and misuse.
Profound sedation, respiratory depression, coma, and death may result from the concomitant use of DSUVIA with benzodiazepines or other CNS depressants. Because of these risks, reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate.
Management of respiratory depression may include close observation, supportive measures, and use of opioid antagonists, depending on the patient’s clinical status.
Presentation and symptoms are non-specific and include nausea, vomiting, anorexia, fatigue, weakness, dizziness and low blood pressure.
LIMITATIONS OF USE
Not for home use or for children.
Discontinue treatment with it before patients leave the certified medically supervised healthcare setting.
Not for use for over 72 hours.
Only administer by a healthcare provider.
Because of the risks of addiction, abuse, and misuse with opioids, even at recommend doses.
Reserve DSUVIA for patients for whom alternative treatment options.
Provide adequate analgesia, or are not expected to provide adequate analgesia.
Significant respiratory depression
Severe bronchial asthma in an elementary setting or in the absence of resuscitative equipment
Known or suspect gastrointestinal obstruction, including paralytic ileus
Known hypersensitivity to sufentanil or components of DSUVIA.
DSUVIA contains one 30 mcg sufentanil tablet housed in a disposable single-dose applicator (SDA). The DSUVIA tablet is an immediate release formulation intended for sublingual administration. Each tablet is blue, flat-faced with a diameter of 3 mm.
The IUPAC chemical name for sufentanil is N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-Nphenylpropanamide citrate. Sufentanil citrate has a molecular weight of 578.4 (molecular weight of free sufentanil base is 386.55), its empirical formula is C28H38N2O9S • C6H8N2O7.